These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29860787)

  • 1. Purposeless Groaning in Parkinson's Disease.
    Lim SY; Tan AH; Lim JL; Ahmad-Annuar A
    J Mov Disord; 2018 May; 11(2):87-88. PubMed ID: 29860787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OFF-Period Purposeless Groaning in Parkinsonism.
    Agarwal V; Rajan J; Ramli N; Santiago C; Jasti DB; Tan AH; Lim SY
    Neurol India; 2022; 70(3):1232-1234. PubMed ID: 35864675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teaching Video NeuroImages: Purposeless groaning in progressive supranuclear palsy.
    Low SC; Tan AH; Lim SY
    Neurology; 2017 Jan; 88(1):e9. PubMed ID: 28025406
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.
    Asahina M; Suhara T; Shinotoh H; Inoue O; Suzuki K; Hattori T
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):155-63. PubMed ID: 9703164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration.
    Tedeschi G; Litvan I; Bonavita S; Bertolino A; Lundbom N; Patronas NJ; Hallett M
    Brain; 1997 Sep; 120 ( Pt 9)():1541-52. PubMed ID: 9313638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The applause sign and neuropsychological profile in progressive supranuclear palsy and Parkinson's disease.
    Somme J; Gómez-Esteban JC; Tijero B; Berganzo K; Lezcano E; Zarranz JJ
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1230-3. PubMed ID: 23253819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontal deficits differentiate progressive supranuclear palsy from Parkinson's disease.
    Lee YE; Williams DR; Anderson JF
    J Neuropsychol; 2016 Mar; 10(1):1-14. PubMed ID: 25223526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
    Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy.
    Giordano A; Tessitore A; Corbo D; Cirillo G; de Micco R; Russo A; Liguori S; Cirillo M; Esposito F; Tedeschi G
    Parkinsonism Relat Disord; 2013 Jun; 19(6):590-4. PubMed ID: 23477861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.
    Tong J; Rathitharan G; Meyer JH; Furukawa Y; Ang LC; Boileau I; Guttman M; Hornykiewicz O; Kish SJ
    Brain; 2017 Sep; 140(9):2460-2474. PubMed ID: 29050386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
    Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG
    Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications.
    Henderson JM; Carpenter K; Cartwright H; Halliday GM
    Brain; 2000 Jul; 123 ( Pt 7)():1410-21. PubMed ID: 10869053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free-water imaging in Parkinson's disease and atypical parkinsonism.
    Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
    Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voluntary Inhibition of Involuntary Groaning in Progressive Supranuclear Palsy.
    Mainka T; Hidding U; Buhmann C; Haggard P; Ganos C
    Mov Disord Clin Pract; 2018; 5(3):325-326. PubMed ID: 30800704
    [No Abstract]   [Full Text] [Related]  

  • 16. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease.
    Aarsland D; Litvan I; Salmon D; Galasko D; Wentzel-Larsen T; Larsen JP
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1215-20. PubMed ID: 12933921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson's disease.
    Dubois B; Pillon B; Legault F; Agid Y; Lhermitte F
    Arch Neurol; 1988 Nov; 45(11):1194-9. PubMed ID: 3190499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.
    Brown RG; Lacomblez L; Landwehrmeyer BG; Bak T; Uttner I; Dubois B; Agid Y; Ludolph A; Bensimon G; Payan C; Leigh NP;
    Brain; 2010 Aug; 133(Pt 8):2382-93. PubMed ID: 20576697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive supranuclear palsy as differential diagnosis of Parkinson's disease in the elderly.
    Fernández-Ferreira R; García-Santos RA; Rodríguez-Violante M; López-Martínez C; Becerra-Laparra IK; Torres-Pérez ME
    Rev Esp Geriatr Gerontol; 2019; 54(5):251-256. PubMed ID: 31324404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.